Skip to content
Cidara Therapeutics Inc icon

Cidara Therapeutics Inc

CDTXStocksPharmaceuticals OtherUnited StatesNasdaqUSD

Price

$221.51

Today

+0.1%

YTD

+0.4%

About

Cidara Therapeutics Inc is a biotechnology company in the US focused on developing novel therapeutics to treat infectious diseases and cancer. It aims to create innovative product candidates leveraging its proprietary technology to address serious medical conditions. Operating primarily within the healthcare and biotechnology sectors, Cidara Therapeutics Inc utilises its proprietary Cloudbreak® platform to discover and advance targeted immunotherapies and anti-infectives. Its research seeks to provide patients with improved treatment options for challenging diseases. Monitor the CDTX share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for CDTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-18.79
P/S (TTM)0.00
P/B (TTM)15.38
Market cap$6.49B
Cap tierMid-cap
Industry avg P/E-19.90

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-68.70%
ROA-54.27%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$11.78
Free cash flow$-132.94M
Total debt$1.98M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.70
Employees38
Next earnings5 Mar '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Cidara Therapeutics Inc (CDTX) | Dirk Kuyken